This prospective 15-year cohort study followed 71 healthcare workers who contracted SARS at a single Beijing hospital in 2003. It tracks serial pulmonary CT, hip MRI, pulmonary function tests, and Harris hip scores to define the natural history of steroid-induced femoral head necrosis and viral pulmonary fibrosis. The central question: does short-term high-dose steroid osteonecrosis behave like the relentlessly progressive disease seen with chronic steroid use?
The conventional teaching on steroid-induced osteonecrosis is that it progresses relentlessly to femoral head collapse — a teaching derived almost entirely from patients on chronic steroids for conditions like leukemia or nephrotic syndrome. This paper establishes that short-term high-dose steroid pulse therapy produces a fundamentally different disease: partially reversible, with all progression confined to the first 4 years and most patients maintaining stable hip function at 15 years.
When you encounter a patient who received a short course of high-dose steroids for viral pneumonia (SARS, and by extension COVID-19 or other severe viral infections), counsel them that osteonecrosis. If it develops. Is not the same beast as chronic steroid AVN. Surveillance MRI in the first 2–4 years is the critical window; after that, structural stability is the expected trajectory.
For pulmonary follow-up in the same patient population, order spirometry with attention to FEV1/FVC and FEF25%–75%, not just DLCO or TLC. Persistent CT changes at 6 months predict small-airway obstruction specifically. And that pattern does not spontaneously recover further after year 1.
This prospective 15-year cohort study followed 71 healthcare workers who contracted SARS at a single Beijing hospital in 2003. It tracks serial pulmonary CT, hip MRI, pulmonary function tests, and Harris hip scores to define the natural history of steroid-induced femoral head necrosis and viral pulmonary fibrosis. The central question: does short-term high-dose steroid osteonecrosis behave like the relentlessly progressive disease seen with chronic steroid use?
The conventional teaching on steroid-induced osteonecrosis is that it progresses relentlessly to femoral head collapse — a teaching derived almost entirely from patients on chronic steroids for conditions like leukemia or nephrotic syndrome. This paper establishes that short-term high-dose steroid pulse therapy produces a fundamentally different disease: partially reversible, with all progression confined to the first 4 years and most patients maintaining stable hip function at 15 years.
When you encounter a patient who received a short course of high-dose steroids for viral pneumonia (SARS, and by extension COVID-19 or other severe viral infections), counsel them that osteonecrosis. If it develops. Is not the same beast as chronic steroid AVN. Surveillance MRI in the first 2–4 years is the critical window; after that, structural stability is the expected trajectory.
For pulmonary follow-up in the same patient population, order spirometry with attention to FEV1/FVC and FEF25%–75%, not just DLCO or TLC. Persistent CT changes at 6 months predict small-airway obstruction specifically. And that pattern does not spontaneously recover further after year 1.